Pure Global
NCT06215066

Effect of Virtual Reality and Progressive Muscle Relaxation on Anxiety and Attention Among Cardiac Care Unit Patients

Effect of Virtual Reality and Modified Progressive Muscle Relaxation Distraction Techniques on Anxiety and Attention Among Cardiac Care Unit Patients; RCT.
Alexandria University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Anxiety
Drug/Device/Intervention
Modified Progressive Muscle Relaxation Exercise
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Alexandria University
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2024
End date
Jun 01, 2024
Enrollment
150 participants
Primary outcome

Comparing the outcomes of the physiological parameter (temperature) for both groups.,Comparing the outcomes of the physiological parameter (heart rate) for both groups.,Comparing the outcomes of the physiological parameter (respiratory rate) for both groups.,Comparing the outcomes of the physiological parameter (oxygen saturation level) for both groups.,Comparing the outcomes of the physiological parameter (pain level) for both groups.,Comparing the outcomes of the physiological parameter (blood pressure) for both groups.,Comparing the outcomes of the anxiety level for both groups.

Summary

This study aims to:
 
 Assess the effect of virtual reality and modified progressive muscle relaxation distraction
 techniques on anxiety, attention and getting distracted from the external environment among
 cardiac care unit patients.
 
 Research hypotheses:
 
 H1: Patients who receive VR intervention have lower Hamilton Anxiety Rating (HAM-A) scores
 than those who receive modified PMR intervention.
 
 H2: Patients who receive VR intervention exhibit improvement in their physiological
 parameters than those who receive modified PMR intervention.
 
 H3: Patients who receive VR intervention have lower Attention/Distraction scores than those
 who receive modified PMR intervention.

ICD-10 classifications
Anxiety disorder, unspecifiedOther anxiety disordersPhobic anxiety disordersPhobic anxiety disorder, unspecifiedGeneralized anxiety disorder
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06215066
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06215066 through Pure Global AI's free database. This phase not specified trial is sponsored by Alexandria University and is currently Not yet recruiting. The study focuses on Anxiety. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.